Back to search

Denmark· DK-28101125283

Trilafon Dekanoat

A perphenazine product containing perphenazindecanoat, registered in Denmark by Orion Corporation. The same ATC class is registered in 9 of our 19 countries.

ATC N05AB03

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedTrilafon DekanoatATCN05AB03REGISTER NO.DK-28101125283PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Perphenazine is registered in 9 of 19 countries.

Countries holding a registration under ATC N05AB03 (perphenazine), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 4 of them publish a price we can compare per daily dose

Perphenazine · ATC N05AB03

9 / 19 countries

  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Japan
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
PERPHENAZINDECANOAT
Manufacturer
Orion Corporation
Country
Denmark (DK)
ATC code
N05AB03
ATC class
Perphenazine
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28101125283

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

371 interactions on record for perphenazine.

Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Perphenazine · interactions on record

371 records

  • 49 severe
  • 285 moderate
  • 11 minor
  • 24 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d97a1987-9923-4af1-9a03-d2d929a9b445
GET /v1/drugs/d97a1987-9923-4af1-9a03-d2d929a9b445?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, opløsning, i.m.",
  "source": "dkma",
  "strength": "108,2 mg/ml",
  "auth_role": "DKMA",
  "dk_drugid": "28101125283",
  "substance": "PERPHENAZINDECANOAT",
  "auth_procedure": "National",
  "in_medicinpriser": true,
  "registration_date_serial": "31085"
}

See everything about perphenazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.